miR Scientific

Mi R Scientific

Biotechnology, 250 Greenwich St, New York, 12229, United States, 51-200 Employees

mirscientific.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 51********

Who is MIR SCIENTIFIC

miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of diseas...

Read More

map
  • 250 Greenwich St, New York, New York, 12229, United States Headquarters: 250 Greenwich St, New York, New York, 12229, United States
  • 2013 Date Founded: 2013
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8711 | NAICS Code: 621399 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from MIR SCIENTIFIC

miR Scientific Org Chart and Mapping

Employees

Rebecca Devaux

Associate Laboratory Director

Philip Caridad

Medical Laboratory Technologist

Ismail Yildiz

Lead Pre-Analytical Technologist

Tim Neuman

Director of Training and Sales Development

Fredy Miguez

Lead Clinical Technologist

James Criss

Senior Research Associate - Assay Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding MiR Scientific

Answer: miR Scientific's headquarters are located at 250 Greenwich St, New York, 12229, United States

Answer: miR Scientific's phone number is 51********

Answer: miR Scientific's official website is https://mirscientific.com

Answer: miR Scientific's revenue is $10 Million to $25 Million

Answer: miR Scientific's SIC: 8711

Answer: miR Scientific's NAICS: 621399

Answer: miR Scientific has 51-200 employees

Answer: miR Scientific is in Biotechnology

Answer: miR Scientific contact info: Phone number: 51******** Website: https://mirscientific.com

Answer: miR Scientific, LLC is a healthcare company committed to transforming global cancer management by providing early and highly accurate detection, characterization, and monitoring of disease. The Company has developed the miR Disease Management Platform, a proprietary, non-invasive platform for the effective management of targeted diseases, initially focused on urological cancers. The platform is powered by the miR Sentinel Prostate Cancer Test, a liquid biopsy urine test that can accurately detect, classify, and monitor prostate cancer based on the interrogation of small-non-coding RNAs extracted from urinary exosomes. miR Scientific is developing interoperable products and services necessary to revolutionize the standards of care supporting urologic oncology, including for prostate, bladder, and other urothelial cancers. Such new standards are urgently needed given the prevalence of these cancers and their debilitating burden globally. miR Scientific is a majority-owned operating subsidiary of Impact NRS LLC, headquartered in New York City with operating subsidiaries in Israel, Canada, and Puerto Rico.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access